Ligand Pharmaceuticals Inc (LGND)
70.57
+0.20
(+0.28%)
USD |
NASDAQ |
Apr 26, 16:00
70.57
0.00 (0.00%)
After-Hours: 20:00
Ligand Pharmaceuticals Free Cash Flow (Quarterly): -42.68M for Dec. 31, 2023
Free Cash Flow (Quarterly) Chart
Historical Free Cash Flow (Quarterly) Data
| Date | Value |
|---|---|
| December 31, 2023 | -42.68M |
| September 30, 2023 | 7.159M |
| June 30, 2023 | -0.285M |
| March 31, 2023 | 31.53M |
| December 31, 2022 | 52.30M |
| September 30, 2022 | 15.20M |
| June 30, 2022 | 5.29M |
| March 31, 2022 | 47.14M |
| December 31, 2021 | 25.45M |
| September 30, 2021 | 18.25M |
| June 30, 2021 | 18.99M |
| March 31, 2021 | 7.35M |
| December 31, 2020 | -1.093M |
| September 30, 2020 | 10.71M |
| June 30, 2020 | 23.59M |
| March 31, 2020 | 16.92M |
| December 31, 2019 | -7.339M |
| September 30, 2019 | -6.197M |
| June 30, 2019 | -61.06M |
| March 31, 2019 | 45.26M |
| December 31, 2018 | 32.57M |
| September 30, 2018 | 27.08M |
| June 30, 2018 | 73.64M |
| March 31, 2018 | 60.76M |
| December 31, 2017 | 31.31M |
| Date | Value |
|---|---|
| September 30, 2017 | 27.65M |
| June 30, 2017 | 10.39M |
| March 31, 2017 | 19.22M |
| December 31, 2016 | 25.71M |
| September 30, 2016 | 16.34M |
| June 30, 2016 | -8.292M |
| March 31, 2016 | 7.43M |
| December 31, 2015 | 11.80M |
| September 30, 2015 | 9.159M |
| June 30, 2015 | 5.583M |
| March 31, 2015 | 4.322M |
| December 31, 2014 | 7.683M |
| September 30, 2014 | 3.467M |
| June 30, 2014 | 3.964M |
| March 31, 2014 | 0.953M |
| December 31, 2013 | 11.03M |
| September 30, 2013 | -0.564M |
| June 30, 2013 | 3.245M |
| March 31, 2013 | 2.041M |
| December 31, 2012 | 2.21M |
| September 30, 2012 | -4.782M |
| June 30, 2012 | -0.974M |
| March 31, 2012 | -4.937M |
| December 31, 2011 | 4.18M |
| September 30, 2011 | -1.166M |
Free Cash Flow Definition
Free cash flow measures the amount of cash left over from a time period after all operational and working capital payments are made. Free cash flow is an important metric because it allows you to view the amount actual cash is available to the company. Free cash flow is also commonly used in valuation calculations like the discounted cash flow valuation model.
Free Cash Flow (Quarterly) Range, Past 5 Years
-61.06M
Minimum
Jun 2019
52.30M
Maximum
Dec 2022
8.486M
Average
10.71M
Median
Sep 2020
Free Cash Flow (Quarterly) Benchmarks
| ANI Pharmaceuticals Inc | 39.96M |
| ADMA Biologics Inc | 16.19M |
| Viking Therapeutics Inc | -6.134M |
| Corcept Therapeutics Inc | 5.887M |
| Palatin Technologies Inc | -10.51M |